Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.
The primary objective was to demonstrate superiority of semaglutide 7.2 mg against placebo on weight loss. Key secondary endpoints included number of participants achieving 10%, 15%, 20% and 25% ...
A new clinical trial suggests that once-weekly semaglutide may reduce alcohol consumption and cravings in adults with alcohol use disorder.
Hosted on MSN4mon
Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetesAbout 37% of individuals prescribed semaglutide for obesity achieved 10% or more body weight reduction ... loss at one year was 2% higher for every unit increase in baseline BMI.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results